Alvotech

IPO

Better Access Better Lives

Alvotech is a biotech company in Reykjavik, Iceland, founded in 2013.

Headquarters
Reykjavik
Employees
501–1000
Founded
2013
Business Model
B2B
Type
Public

Indexed holds 7 investors for this company. to use credits for reveals, or explore the API.

About

Alvotech develops and manufactures high-quality, cost-competitive biosimilars to broaden the availability of biologic medicines to patients around the world. The company believes that if there is a proven biologic medicine, it should be accessible to all patients in need. That commitment to the promise of biosimilars is foundational to Alvotech's approach, culture, and purpose of creating a healthier world through affordable biologics.

Exit History

Data from Indexed.vcUpdated
SPAC MergerSPAC MergerDec 2021
$450.0M

4 more events

  • Debt Financing20211 investor
  • Debt Financing20201 investor
  • Debt Financing2018

Funding, valuations, and company events, with amounts and investors where available.

Investors

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Backend ×2
  • Cloud/Infrastructure ×2
  • Frontend ×1
  • Marketing & SEO ×1
  • Productivity & Collaboration ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alvotech on Indexed.vc
<a href="https://indexed.vc/companies/alvotech"><img src="https://indexed.vc/api/badge/company/alvotech" alt="Alvotech on Indexed.vc" width="260" height="76" /></a>